Evoke Pharma Inc (EVOK.OQ)
EVOK.OQ on NASDAQ Stock Exchange Capital Market
2.34USD
24 Apr 2018
2.34USD
24 Apr 2018
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$2.34
$2.34
Open
$2.33
$2.33
Day's High
$2.37
$2.37
Day's Low
$2.33
$2.33
Volume
2,066
2,066
Avg. Vol
15,447
15,447
52-wk High
$4.09
$4.09
52-wk Low
$1.86
$1.86
Select another date:
Mon, Mar 26 2018
BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments
* EVOKE ANNOUNCES AGREEMENT WITH MALLINCKRODT TO AMEND MILESTONE PAYMENTS
BRIEF-Evoke Pharma Q4 Loss Per Share $0.02
* EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS
BRIEF-Mr Green Acquires Evoke Gaming Including Redbet
* PURCHASE PRICE OF EUR 7 MILLION IN CASH; AN ADDITIONAL PURCHASE PRICE OF EUR 1.5 MILLION MAY BE PAYABLE IF CERTAIN CONDITIONS ARE MET
BRIEF-Evoke Pharma reports Q3 loss per share $0.34
* Evoke Pharma reports third quarter 2017 results and highlights
BRIEF-Evoke Pharma signs commercial agreement with Thermo Fisher Scientific
* Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti
Select another date:
- Evoke Pharma's (EVOK) CEO Dave Gonyer on Q4 2017 Results - Earnings Call Transcript
- Your Daily Pharma Scoop: AbbVie's Upadacitinib, Johnson & Johnson's Tremfya, Celgene Reports Results For Otezla
- Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2017 Results - Earnings Call Transcript
- Evoke Pharma's (EVOK) CEO Dave Gonyer on Q2 2017 Results - Earnings Call Transcript
- Evoke Pharma's (EVOK) CEO David Gonyer on Q1 2017 Results - Earnings Call Transcript
- Evoke Pharma's (EVOK) CEO David Gonyer on Q4 2016 Results - Earnings Call Transcript